Browsing Centre for Molecular Oncology by Author "Radon, TP"
Now showing items 1-4 of 4
-
AGR2, a unique tumor-associated antigen, is a promising candidate for antibody targeting.
Liu, AY; Kanan, AD; Radon, TP; Shah, S; Weeks, ME; Foster, JM; Sosabowski, JK; Dumartin, L; Crnogorac-Jurcevic, T (2019-07-02)Anterior gradient 2 (AGR2), a protein disulfide isomerase, shows two subcellular localizations: intracellular (iAGR2) and extracellular (eAGR2). In healthy cells that express AGR2, the predominant form is iAGR2, which ... -
ER stress protein AGR2 precedes and is involved in the regulation of pancreatic cancer initiation
Dumartin, L; Alrawashdeh, W; Trabulo, SM; Radon, TP; Steiger, K; Feakins, RM; di Magliano, MP; Heeschen, C; Esposito, I; Lemoine, NR (2017-06-01) -
Perineural invasion in pancreatic cancer: proteomic analysis and in vitro modelling.
Alrawashdeh, W; Jones, R; Dumartin, L; Radon, TP; Cutillas, PR; Feakins, RM; Dmitrovic, B; Demir, IE; Ceyhan, GO; Crnogorac-Jurcevic, T (FEBS Press and John Wiley & Sons Ltd., 2019-01-28)Perineural invasion (PNI) is a common and characteristic feature of pancreatic ductal adenocarcinoma (PDAC) that is associated with poor prognosis, tumor recurrence, and generation of pain. However, the molecular alterations ... -
Splice variants as novel targets in pancreatic ductal adenocarcinoma
Wang, J; Dumartin, L; Mafficini, A; Ulug, P; Sangaralingam, A; Alamiry, NA; Radon, TP; Salvia, R; Lawlor, RT; Lemoine, NR (2017-06-07)